KT Corp/ US48268K1016 /
2024-07-29 10:10:00 PM | Chg. +0.05 | Volume | Bid1:01:06 AM | Ask1:01:06 AM | High | Low |
---|---|---|---|---|---|---|
14.15USD | +0.35% | 315,986 Turnover: 3.27 mill. |
13.88Bid Size: 100 | 14.25Ask Size: 1,000 | 14.20 | 14.08 |
GlobeNewswire
06-24
Zapata AI Joins KT Consortium to Help Transform Chemical Engineering Processes Using Generative AI
GlobeNewswire
06-20
Biotechs Race to Develop New Treatments as Global Pancreatic Cancer Market Size Expected to Reach $7...
GlobeNewswire
06-14
Summit Nanotech and Zelandez Collaborate to Accelerate Modular Lithium Carbonation Project in South ...
GlobeNewswire
06-14
Kymera Therapeutics Presents New Clinical Data from the Ongoing Phase 1 Trial of STAT3 Degrader KT-3...
GlobeNewswire
06-01
Kymera Therapeutics Presents New Clinical Data from Ongoing Phase 1 Trial of MDM2 Degrader KT-253 at...
GlobeNewswire
05-29
Lithium Ionic Announces Feasibility Study Results for the Bandeira Lithium Project, Minas Gerais, Br...
Newsfile Corp
05-29
Kardome Partners with KT Corporation to Provide Voice AI Technology to IPTV Service Users
GlobeNewswire
05-23
Kymera Therapeutics to Present New Clinical Data from Ongoing Phase 1 Trial of MDM2 Degrader KT-253 ...
GlobeNewswire
05-22
Kymera Therapeutics Presents New Preclinical Data for KT-621, a First-In-Class, Oral STAT6 Degrader ...
GlobeNewswire
05-15
Caledonia Mining Corporation Plc: Increases in mineral resources and mineral reserves estimates at B...
GlobeNewswire
05-14
Kymera Therapeutics to Present New Clinical Data from the Ongoing Phase 1 Trial of STAT3 Degrader KT...
GlobeNewswire
05-06
K92 Mining Announces Latest Drilling Results Extending Multiple High-Grade Zones and New Dilatant Zo...